Delivery Order SPE2DB20D1100-SPE2DB25FE6M2
- Not listed
- This federal contract award is a delivery order valued at $4,157.73 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the supply of Sutent 12.5 mg capsules and has a final completion date of December 23, 2024. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for $11,488.74. The contract is a Firm Fixed Price Delivery Order for the supply of SUTENT 37.5 MG CAPSULE 28S to support military healthcare programs. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a $24,876 firm fixed price delivery order to Amerisourcebergen Drug Corporation for SUTENT 50 MG CAPSULE 28S. To be performed in Conshohocken, Pennsylvania from June 15, 2023 through July 10, 2023, this order is likely placed against DLA's Pharmaceutical Prime Vendor contract to supply oncology pharmaceuticals for DOD medical treatment facilities. As the prime, Amerisourcebergen will deliver the requested capsules without use of major subcontractors. DLA...
- This federal contract award, with the ID SPE2DX15D3012|SPE2DX24F8KV8, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of 4564002322 - SUTENT 25 MG CAPSULE 28S, a specialty pharmaceutical product, with a firm fixed price ceiling value of $7,993.88 and a period of performance through...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 28-count bottles of the pharmaceutical product SUTENT 25 MG CAPSULE. The contract has a completion date of March 18, 2024, an award date of February 26, 2024, and a potential value of $7,993.88. This delivery order is not associated with a set-aside designation. Amerisourcebergen Drug Corp, as the...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for $23,981.64. The contract is for the supply of the pharmaceutical product SUTENT 25 MG CAPSULE 28S, with a performance period ending on October 30, 2024. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor for this award. The contract does not have a set-aside designation. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs)...
- The Defense Logistics Agency Troop Support Medical awarded a $7,733.98 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of 4562524133 SUTENT 12.5 MG CAPSULE 28S. The contract has no set-aside designation and requires completion by November 8, 2023. To be performed in Conshohocken, Pennsylvania, this order is likely supporting the DLA Troop Support Medical's provision of pharmaceutical supplies to military...
- The Defense Logistics Agency awarded a $35,205.19 delivery order to AmerisourceBergen Drug Corp for Sunitinib Malate 25 mg capsules (28-count packaging) on September 12, 2025, with an ultimate completion date of September 15, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The pharmaceutical product will be performed and shipped...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Sunitinib Malate 50 mg capsules (28-count packages) with a ceiling value of $22,358.72. This firm fixed-price delivery order, with an ultimate completion date of July 29, 2025, represents a competitively awarded, non-set-aside contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Sunitinib Malate 37.5 mg capsules (28-count) with a ceiling value of $9,141.79. This is a firm fixed price delivery order with no set-aside designation, completed competitively. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 10, 2025. This delivery order is issued under...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE6M2Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,940.52 to AmerisourceBergen Drug Corp for the supply of Sutent 37.5 mg capsules (quantity: 28 units). This firm fixed-price, competitively awarded contract is scheduled for completion by October 3, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company holds a comprehensive $999,999,999 IDC with DLA Troop Support Medical (SPE2DX) extending through December 2026, which provides a global pharmaceutical support vehicle for supplying a broad range of medications, vaccines, medical devices, and healthcare commodities across multiple therapeutic domains. This delivery order for Sutent—a specialized cancer treatment medication—exemplifies AmerisourceBergen's role in fulfilling Department of Defense healthcare requirements through flexible contracting vehicles designed to support military health programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.9k | 9/12/25 |